1 October 2018 - The Biosafety Advisory Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A first-time-in human, Phase I, study to evaluate the reactogenicity, safety immunogenicity and efficacy of HBV viral vectored vaccines given in a prime-boost schedule in chronic Hepatitis B patients